Report : South and Central America Tissue Sectioning Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product [Instruments (Rotary Microtome, Ultramicrotome, Cryostat, Sliding Microtome, and Others), Accessories and Consumables, and Services], Technology (Automatic, Semiautomatic, and Manual), Application (Diagnosis, and Research), and End User (Hospitals, Clinics, Diagnostic Laboratories, Digital Path Labs, and Others)
The instruments segment by product is estimated to lead the market growth during the forecast period.
According to a new market research study of “South and Central America Tissue Sectioning Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Product, Technology, Application, End User and Country.” The South and Central America tissue sectioning market is expected to reach US$ 52.63 million by 2028 from US$ 35.85 million in 2021. It is estimated to grow at a CAGR of 5.6% from 2021 to 2028.The report highlights trends prevailing in the South and Central America tissue sectioning market and the factors driving market along with those that act as hindrances.
Under the Ministry of Health and Family Welfare (MoHFW) and the Government of India, the NHM backed all states to provide essential diagnostics at their public health installations free of cost in India. Taking this initiative to global position, the WHO released the original edition of the Essential Diagnostics List (EDL) in May 2018. Fastening on the significance of diagnosis, the WHO stated the testing affects the majority of medical opinions. Appropriate diagnostic tests can inform evidence-based treatment and accountable use of medicines, performing in the overall bettered allocation of resources and better health outcomes.
With a remarkable rise in the aging population, several chronic ailments cases are showing an increase, leading to the necessity toward prevention and cure from a disorder, and, hence, the medical decision. Tissue sectioning (including necropsies, surgical or necropsy samples) is a core part of histopathological examinations, on which the physicians can blindly rely for the result accuracy. The superficial tissue sections may not represent the whole necropsy, which leads to repeated requests for deeper sections to enhance sensitivity and diagnostic delicacy. The data mentioned above and factors are performing in an increase in the number of remedial establishments. For illustration, pathology laboratories and clinics have increased the appropriation of tissue sectioning. These developments and rapid adoption are shifting the focus of pathologists and researchers toward exploring other approaches. Also, this massive contribution to ineffective treatments with the aid of histopathological examination is a significant factor in the growth of the tissue sectioning market.
South and Central America has been witnessing a significant number of COVID-19 cases; the increasing number of cases in Brazil, Peru, Chile, Ecuador, and Venezuela is likely to impact the market negatively. A considerable number of countries in South America have very underdeveloped healthcare infrastructure. For instance, Peru has less than 1000 intensive care unit beds for its 32 million inhabitants. Furthermore, supply chain disruption caused due to congestion of ports and disturbances in other transport means had a substantial impact on the distribution of associated devices in the region. As the focus on COVID-19 patients became critical, the non-urgent medical procedures took a back seat. Several clinics have postponed or dropped numerous elective surgeries, especially those considered non-urgent. The markets associated with tissue sectioning, such as histopathological diagnosis, would be severely affected. All these factors considerably deterred the growth of the South and Central America tissue sectioning market. However, the number of tissue sections again started to gain momentum as the number of COVID-19 confirmations declined.
Based on the product, the South and Central America tissue sectioning market is segmented into instruments, accessories & consumables, and services. The instruments segment is further sub-segmented into rotary microtome, ultramicrotome, cryostat, sliding microtome, and others. Based on the technology, the South and Central America tissue sectioning market is segmented into automatic, semiautomatic, and manual. Based on application, the South and Central America tissue sectioning market is segmented into diagnosis and research. The South and Central America tissue sectioning market is segmented into hospitals, clinics, diagnostic laboratories, digital path labs, and others based on the end user. Geographically, the South and Central America tissue sectioning market is sub-segmented into Brazil, Argentina and Rest of South and Central America.
THERMO FISHER SCIENTIFIC, INC., Leica Biosystems Nussloch GmbH (Danaher), Diapath S.p.A, MEDITE Medical GmbH and Abcam Plc are among the leading companies operating in the South and Central America tissue sectioning market.
Contact Person: Sameer Joshi
Email Id: email@example.com